These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32865165)

  • 1. Rapid skin thickness progression rate is associated with high incidence rate of cardiopulmonary complications in patients with early diffuse cutaneous systemic sclerosis: inception cohort study.
    Wangkaew S; Thongwitokomarn H; Prasertwittayakij N; Euathrongchit J
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):98-105. PubMed ID: 32865165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study.
    Wangkaew S; Tungteerabunditkul S; Prasertwittayakij N; Euathrongchit J
    Clin Rheumatol; 2020 Jan; 39(1):103-112. PubMed ID: 31004303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study.
    Wangkaew S; Intum J; Prasertwittayakij N; Euathrongchit J
    Clin Rheumatol; 2022 Oct; 41(10):3055-3063. PubMed ID: 35794291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study.
    Wangkaew S; Phiriyakrit P; Sawangduan V; Prasertwittayakij N; Euathrongchit J
    Int J Rheum Dis; 2018 May; 21(5):1082-1092. PubMed ID: 29673120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study.
    Wangkaew S; Pota P; Prasertwittayakij N; Phrommintikul A
    Clin Rheumatol; 2021 Mar; 40(3):973-980. PubMed ID: 32683661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
    Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles.
    Wangkaew S; Prasertwittayakij N; Euathrongchit J
    J Clin Med Res; 2019 Jul; 11(7):524-531. PubMed ID: 31236172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort.
    Jaafar S; Lescoat A; Huang S; Gordon J; Hinchcliff M; Shah AA; Assassi S; Domsic R; Bernstein EJ; Steen V; Elliott S; Hant F; Castelino FV; Shanmugam VK; Correia C; Varga J; Nagaraja V; Roofeh D; Frech T; Khanna D
    Arthritis Res Ther; 2021 Jun; 23(1):170. PubMed ID: 34127049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
    Wu W; Jordan S; Graf N; de Oliveira Pena J; Curram J; Allanore Y; Matucci-Cerinic M; Pope JE; Denton CP; Khanna D; Distler O;
    Ann Rheum Dis; 2019 May; 78(5):648-656. PubMed ID: 30852552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
    Wannarong T; Muangchan C
    Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
    Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
    Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
    Maurer B; Graf N; Michel BA; Müller-Ladner U; Czirják L; Denton CP; Tyndall A; Metzig C; Lanius V; Khanna D; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1124-31. PubMed ID: 24981642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and survival of cardiomyopathy determined by echocardiography in Thai patients with early systemic sclerosis: an inception cohort study.
    Wangkaew S; Prasertwitayakij N; Intum J; Euathrongchit J
    Sci Rep; 2023 Apr; 13(1):6983. PubMed ID: 37117322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.
    Wangkaew S; Sivasomboon C; Leungwatthananon W; Kasitanon N; Louthrenoo W
    Int J Rheum Dis; 2018 Jan; 21(1):240-248. PubMed ID: 27456855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis.
    Ostojic P; Damjanov N
    Rheumatol Int; 2011 Aug; 31(8):1051-4. PubMed ID: 20309694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N
    Quant Imaging Med Surg; 2016 Aug; 6(4):381-390. PubMed ID: 27709074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.
    Gordon JK; Martyanov V; Magro C; Wildman HF; Wood TA; Huang WT; Crow MK; Whitfield ML; Spiera RF
    Arthritis Res Ther; 2015 Aug; 17(1):213. PubMed ID: 26283632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.